CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses

Author(s):
Rosalia, R.A.; Cruz, L.J.; Duikeren, S. van; Tromp, A.T.; Silva, A.L.; Jiskoot, W.; Gruijl, T. de; Lowik, C.; Oostendorp, J.; Burg, S.H. van der (0000-0002-6556-0354); Ossendorp, F.
Published
2015
Publication type
Article / Letter to editor
PLGA nanoparticlesVaccineDCTargetingTLR ligandsCD40
Date issued
2015-02-28
Language
English
Is part of
Biomaterials (2015), Vol. 40, p. 88-97
hdl
1887/106791
doi
10.1016/j.biomaterials.2014.10.053